These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
551 related articles for article (PubMed ID: 17765643)
1. Predictive value of preintervention C-reactive protein on clinical outcome after directional coronary atherectomy followed by stent implantation. Niccoli G; Ferrante G; Mongiardo R; Perfetti M; Belloni F; Burzotta F; Porto I; Leone AM; Rebuzzi AG; Crea F Cardiovasc Revasc Med; 2007; 8(3):156-60. PubMed ID: 17765643 [TBL] [Abstract][Full Text] [Related]
2. Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention. Delhaye C; Sudre A; Lemesle G; Maréchaux S; Broucqsault D; Hennache B; Bauters C; Lablanche JM Cardiovasc Revasc Med; 2009; 10(3):144-50. PubMed ID: 19595394 [TBL] [Abstract][Full Text] [Related]
3. Increased C-reactive protein level after coronary stent implantation in patients with stable coronary artery disease. Almagor M; Keren A; Banai S Am Heart J; 2003 Feb; 145(2):248-53. PubMed ID: 12595841 [TBL] [Abstract][Full Text] [Related]
4. Impact of multivessel coronary artery disease on early ischemic injury, late clinical outcome, and remodeling in patients with acute myocardial infarction treated by primary coronary angioplasty. Tarantini G; Napodano M; Gasparetto N; Favaretto E; Marra MP; Cacciavillani L; Bilato C; Osto E; Cademartiri F; Musumeci G; Corbetti F; Razzolini R; Iliceto S Coron Artery Dis; 2010 Mar; 21(2):78-86. PubMed ID: 20071979 [TBL] [Abstract][Full Text] [Related]
5. Long-term prognostic value of preprocedural C-reactive protein after drug-eluting stent implantation. Delhaye C; Maluenda G; Wakabayashi K; Ben-Dor I; Lemesle G; Collins SD; Syed AI; Torguson R; Kaneshige K; Xue Z; Suddath WO; Satler LF; Kent KM; Lindsay J; Pichard AD; Waksman R Am J Cardiol; 2010 Mar; 105(6):826-32. PubMed ID: 20211326 [TBL] [Abstract][Full Text] [Related]
6. Combined periprocedural evaluation of CRP and TNF-alpha enhances the prediction of clinical restenosis and major adverse cardiac events in patients undergoing percutaneous coronary interventions. Kubica J; Kozinski M; Krzewina-Kowalska A; Zbikowska-Gotz M; Dymek G; Sukiennik A; Piasecki R; Bogdan M; Grzesk G; Chojnicki M; Dziedziczko A; Sypniewska G Int J Mol Med; 2005 Jul; 16(1):173-80. PubMed ID: 15942695 [TBL] [Abstract][Full Text] [Related]
7. Usefulness of preprocedural soluble CD40 ligand for predicting restenosis after percutaneous coronary intervention in patients with stable coronary artery disease. Türker S; Güneri S; Akdeniz B; Ozcan MA; Baris N; Badak O; Kirimli O; Yüksel F Am J Cardiol; 2006 Jan; 97(2):198-202. PubMed ID: 16442363 [TBL] [Abstract][Full Text] [Related]
8. Long-term clinical outcomes after sirolimus-eluting stent implantation for treatment of restenosis within bare-metal versus drug-eluting stents. Whan Lee C; Kim SH; Suh J; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ Catheter Cardiovasc Interv; 2008 Apr; 71(5):594-8. PubMed ID: 18311841 [TBL] [Abstract][Full Text] [Related]
9. Stent implantation, but not pathogen burden, is associated with plasma C-reactive protein and interleukin-6 levels after percutaneous coronary intervention in patients with stable angina pectoris. Saleh N; Svane B; Jensen J; Hansson LO; Nordin M; Tornvall P Am Heart J; 2005 May; 149(5):876-82. PubMed ID: 15894971 [TBL] [Abstract][Full Text] [Related]
10. Relation of C-reactive protein level and long-term risk of death or myocardial infarction following percutaneous coronary intervention with a sirolimus-eluting stent. Karha J; Bavry AA; Rajagopal V; Henderson MR; Ellis SG; Brener SJ Am J Cardiol; 2006 Sep; 98(5):616-8. PubMed ID: 16923447 [TBL] [Abstract][Full Text] [Related]
11. Serum hepatocyte growth factor levels predict long-term clinical outcome after percutaneous coronary revascularization. Susen S; Sautière K; Mouquet F; Cuilleret F; Chmaït A; McFadden EP; Hennache B; Richard F; de Groote P; Lablanche JM; Dallongeville J; Bauters C; Jude B; Van Belle E Eur Heart J; 2005 Nov; 26(22):2387-95. PubMed ID: 16105849 [TBL] [Abstract][Full Text] [Related]
12. Pre-procedural plasma levels of C-reactive protein and interleukin-6 do not predict late coronary angiographic restenosis after elective stenting. Segev A; Kassam S; Buller CE; Lau HK; Sparkes JD; Connelly PW; Seidelin PH; Natarajan MK; Cohen EA; Strauss BH Eur Heart J; 2004 Jun; 25(12):1029-35. PubMed ID: 15191773 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of myeloperoxidase in coronary artery disease: comparison of unstable and stable angina patients. Roman RM; Camargo PV; Borges FK; Rossini AP; Polanczyk CA Coron Artery Dis; 2010 May; 21(3):129-36. PubMed ID: 20305551 [TBL] [Abstract][Full Text] [Related]
14. Are drug-eluting stents indicated in large coronary arteries? Insights from a multi-centre percutaneous coronary intervention registry. Yan BP; Ajani AE; New G; Duffy SJ; Farouque O; Shaw J; Sebastian M; Lew R; Brennan A; Andrianopoulos N; Reid C; Clark DJ; Int J Cardiol; 2008 Nov; 130(3):374-9. PubMed ID: 18706719 [TBL] [Abstract][Full Text] [Related]
15. Prevalence and prognostic significance of preprocedural cardiac troponin elevation among patients with stable coronary artery disease undergoing percutaneous coronary intervention: results from the evaluation of drug eluting stents and ischemic events registry. Jeremias A; Kleiman NS; Nassif D; Hsieh WH; Pencina M; Maresh K; Parikh M; Cutlip DE; Waksman R; Goldberg S; Berger PB; Cohen DJ; Circulation; 2008 Aug; 118(6):632-8. PubMed ID: 18645057 [TBL] [Abstract][Full Text] [Related]